OnKure Therapeutics, Inc. (OKUR)

OnKure Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Oct 25, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	1.03	0.02	0.06
Debt / FCF Ratio	-0.18	-0.02	-0.02
Quick Ratio	1.44	4.10	2.08
Current Ratio	1.83	4.64	2.46
Return on Equity (ROE)	-	-186.07%	-
Return on Assets (ROA)	-	-89.24%	-
Return on Capital (ROIC)	-	-117.58%	-

Source: S&P Capital IQ. Standard template. Financial Sources.